GAA and Hyperglycemia: Antidiabetic medications that target postprandial hyperglycemia such as alpha-glucosidase inhibitors (AGI) and glucagon-like peptide 1 (GLP-1) agonists can lower cardiovascular event rates in T2DM, partly through reduction of plasma LDL cholesterol levels [24,25].